73 related articles for article (PubMed ID: 23515917)
1. Computed tomography-guided interstitial high dose rate brachytherapy for centrally located liver tumours: a single institution study.
Tselis N; Chatzikonstantinou G; Kolotas C; Milickovic N; Baltas D; Zamboglou N
Eur Radiol; 2013 Aug; 23(8):2264-70. PubMed ID: 23515917
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers.
Lai TS; Francoeur A; Manrriquez E; Venkat P; Chang A; Douek M; Bahrami S; Raman SS; Memarzadeh S
Brachytherapy; 2024; 23(3):266-273. PubMed ID: 38453533
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
4. Single fraction computed tomography-guided high-dose-rate brachytherapy or stereotactic body radiotherapy for primary and metastatic lung tumors?
Chan MK; Lee VW; Kadoya N; Chiang CL; Wong MY; Leung RW; Cheung S; Blanck O
J Contemp Brachytherapy; 2018 Oct; 10(5):446-453. PubMed ID: 30479622
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma.
Bretschneider T; Mohnike K; Hass P; Seidensticker R; Göppner D; Dudeck O; Streitparth F; Ricke J
J Contemp Brachytherapy; 2015 Apr; 7(2):154-60. PubMed ID: 26034497
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation.
Auer TA; Anhamm M; Böning G; Fehrenbach U; Schöning W; Lurje G; Gebauer B; Collettini F
Eur J Surg Oncol; 2024 May; 50(7):108429. PubMed ID: 38788357
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography-based flap brachytherapy for non-melanoma skin cancers of the face.
Gogineni E; Cai H; Carillo D; Rana Z; Bloom B; Potters L; Gaballa H; Ghaly M
J Contemp Brachytherapy; 2021 Feb; 13(1):51-58. PubMed ID: 34025737
[TBL] [Abstract][Full Text] [Related]
8. Salvage High-Dose-Rate Interventional Radiotherapy (Brachytherapy) Combined with Surgery for Regionally Relapsed Head and Neck Cancers.
Soror T; Paul J; Melchert C; Idel C; Rades D; Bruchhage KL; Kovács G; Leichtle A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760518
[TBL] [Abstract][Full Text] [Related]
9. Post-operative KEloids iRradiation (POKER): does the surgery/high-dose interventional radiotherapy association make a winning hand?
Franzetti J; Durante S; Mastroleo F; Volpe S; De Lorenzi F; Rotondi M; Lorubbio C; Vitullo A; Frassoni S; Bagnardi V; Cambria R; Cattani F; Vavassori A; Jereczek-Fossa BA
Radiol Med; 2024 Feb; 129(2):328-334. PubMed ID: 38280971
[TBL] [Abstract][Full Text] [Related]
10. Selective internal radiation therapy for liver tumours.
Sundram FX; Buscombe JR
Clin Med (Lond); 2017 Oct; 17(5):449-453. PubMed ID: 28974597
[TBL] [Abstract][Full Text] [Related]
11. Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II Trial.
Mohnike K; Steffen IG; Seidensticker M; Hass P; Damm R; Peters N; Seidensticker R; Schütte K; Arend J; Bornschein J; Streitparth T; Wybranski C; Wieners G; Stübs P; Malfertheiner P; Pech M; Ricke J
Cardiovasc Intervent Radiol; 2019 Feb; 42(2):239-249. PubMed ID: 30488303
[TBL] [Abstract][Full Text] [Related]
12. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
[TBL] [Abstract][Full Text] [Related]
13. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
[TBL] [Abstract][Full Text] [Related]
14. Combined CT-guided high-dose-rate brachytherapy (CT-HDRBT) and transarterial chemoembolization with irinotecan-loaded microspheres improve local tumor control and progression-free survival in patients with unresectable colorectal liver metastases compared with mono-CT-HDRBT.
Friedrich S; Busch F; Jonczyk M; Wieners G; Böning G; Lüdemann WM; Meddeb A; Collettini F; Gebauer B
J Contemp Brachytherapy; 2023 Feb; 15(1):15-26. PubMed ID: 36970444
[TBL] [Abstract][Full Text] [Related]
15. Single-fraction high-dose-rate brachytherapy: a scoping review on outcomes and toxicities for all disease sites.
Kazemi M; Nadarajan S; Kamrava M
J Contemp Brachytherapy; 2022 Oct; 14(5):481-494. PubMed ID: 36478697
[TBL] [Abstract][Full Text] [Related]
16. Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patient.
Appalanaido GK; Ahmad MZ; Shukor SA; Cheen Hoe AK; Subramaniam MK; Fan AS; Abdul Aziz MZ
Hepat Oncol; 2022 Sep; 9(3):HEP44. PubMed ID: 36176484
[TBL] [Abstract][Full Text] [Related]
17. The American Brachytherapy Society consensus statement for permanent implant brachytherapy using Yttrium-90 microsphere radioembolization for liver tumors.
Sharma NK; Kappadath SC; Chuong M; Folkert M; Gibbs P; Jabbour SK; Jeyarajah DR; Kennedy A; Liu D; Meyer JE; Mikell J; Patel RS; Yang G; Mourtada F
Brachytherapy; 2022; 21(5):569-591. PubMed ID: 35599080
[TBL] [Abstract][Full Text] [Related]
18. Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors.
Karagiannis E; Strouthos I; Leczynski A; Zamboglou N; Ferentinos K
Front Oncol; 2022; 12():800920. PubMed ID: 35299745
[TBL] [Abstract][Full Text] [Related]
19. Case Report-Staged brachytherapy achieving complete metabolic response in unresectable oligometastatic colorectal cancer to the liver.
Appalanaido GK; Bahajjaj SIBZ; Shukor SA; Ahmad MZ; Francis HCH
Oxf Med Case Reports; 2021 Apr; 2021(4):omab016. PubMed ID: 33948189
[TBL] [Abstract][Full Text] [Related]
20. First report on extended distance between tumor lesion and adjacent organs at risk using interventionally applied balloon catheters: a simple procedure to optimize clinical target volume covering effective isodose in interstitial high-dose-rate brachytherapy of liver malignomas.
Hass P; Steffen IG; Powerski M; Mohnike K; Seidensticker M; Meyer F; Brunner T; Damm R; Willich C; Walke M; Karagiannis E; Omari J; Ricke J
J Contemp Brachytherapy; 2019 Apr; 11(2):152-161. PubMed ID: 31139224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
